Related Experiment Video

Updated: May 29, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Cancer vaccines at an inflexion point: what next?

Adrian Bot1, Mihail Obrocea, Francesco M Marincola

  • 1Kite Pharma, Inc., Los Angeles CA 90024, USA.

Journal of Translational Medicine
|September 13, 2011
PubMed

Insights

The first therapeutic cancer vaccines for animals and humans mark a milestone. New technologies integrate lessons learned to improve cancer treatment by merging active and passive immunotherapies.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • The recent approval of the first therapeutic cancer vaccines for both veterinary and human use signifies a major advancement in oncology.
  • Despite this milestone, significant challenges remain in fully realizing the potential of cancer vaccines due to their distinct mechanisms compared to conventional therapies.

Purpose of the Study:

  • To provide a synopsis of the latest advances in cancer vaccine technologies.
  • To highlight the challenges and ongoing efforts in the field of cancer immunotherapy.
  • To discuss novel platform technologies integrating lessons from clinical trials.

Main Methods:

  • Review of current cancer vaccine technologies in various developmental stages.
  • Analysis of clinical testing outcomes for cancer vaccines and immune interventions.
  • Exploration of emerging platform technologies that combine active and passive immunotherapy approaches.

Main Results:

  • Cancer vaccine development has overcome numerous obstacles to reach a significant milestone with recent approvals.
  • New platform technologies are emerging that integrate clinical findings and blur the lines between active and passive immunotherapies.
  • These advancements hold promise for fundamentally improving cancer patient management.

Conclusions:

  • Therapeutic cancer vaccines represent a paradigm shift in cancer treatment.
  • Overcoming developmental hurdles and integrating research lessons are crucial for optimizing vaccine efficacy.
  • Innovative immunotherapy platforms are poised to transform cancer care and patient outcomes.

More Related Videos

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...